Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Symbiox Investment & Trading Company Ltd (NSE: SYMBIOX), ISIN INE653R01012 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SYMBIOX last traded at ₹1.67 (-1.76%), with a 52-week range of ₹1.36 to ₹3.05 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 3.33%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 16/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.